TUMOUR NECROSIS FACTOR INHIBITORS AND THE RISK OF ACUTE CORONARY SYNDROMES IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Ljung, L. [1 ,2 ]
Askling, J. [2 ]
Rantapaa-Dahlqvist, S. [1 ]
Jacobsson, L. [3 ]
机构：
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2849
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0182
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] TUMOUR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, A. R.
    Martins Rocha, T.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, C.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1584 - 1585
  • [32] ANTI TUMOUR NECROSIS FACTOR THERAPY IN RHEUMATOID ARTHRITIS: THE RISK OF TUBERCULOSIS
    Langtree, Matthew
    Lam, Manda
    Malipeddi, Aruna
    Hassan, Waji
    RHEUMATOLOGY, 2010, 49 : I92 - I92
  • [33] Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis
    Nilsson, Anna Christine
    Christensen, Anne Friesgaard
    Junker, Peter
    Lindegaard, Hanne Merete
    DANISH MEDICAL BULLETIN, 2011, 58 (04)
  • [34] Tumour necrosis factor blockade in rheumatoid arthritis
    Breedveld, FC
    CLINICAL MEDICINE, 2001, 1 (02) : 107 - 109
  • [35] Melanoma risk in patients with rheumatoid arthritis treated with tumour necrosis factor alpha inhibitors: a systematic review and meta-analysis
    Olsen, Catherine M.
    Hyrich, Kimme L.
    Knight, Lani L.
    Green, Adele C.
    MELANOMA RESEARCH, 2016, 26 (05) : 517 - 523
  • [36] Outcomes After Acute Coronary Syndromes in Patients With Rheumatoid Arthritis
    Prabhakaran, Anbazhagan
    Rajamanickam, Anitha
    Roukoz, Henri
    Jain, Anil
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A336 - A336
  • [37] A MODEL TO EVALUATE THE IMMUNOGENICITY COSTS OF TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Heeg, B.
    Majer, I
    Stephens, J. M.
    Tarallo, M.
    VALUE IN HEALTH, 2013, 16 (07) : A563 - A563
  • [38] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Moreland, LW
    PHARMACOECONOMICS, 2004, 22 (02) : 39 - 53
  • [39] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Larry W. Moreland
    PharmacoEconomics, 2004, 22 : 39 - 53
  • [40] Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
    Zahra Rezaieyazdi
    Jalil Tavakol Afshari
    Mahnaz Sandooghi
    Farnaz Mohajer
    Rheumatology International, 2007, 28 : 189 - 191
12345